Equels Thomas K bought AIM
October 22, 2026 · Form 4 insider transaction
Equels Thomas K bought 31,250 shares of AIM ImmunoTech Inc. at $0.16 per share, a transaction worth $5.1K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
31,250
Price
$0.16
Total value
$5.1K
InsiderEquels Thomas K
Role—
CompanyAIM ImmunoTech Inc. (AIM)
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateOctober 22, 2026
Filing dateOctober 23, 2026
Shares owned after158,072
OwnershipDirect
10b5-1 planNo
AmendedNo